Contract Manufacturing News in Brief

Outsourcing-Pharma.com

 

December 10, 2007

 


By Staff Reporter

New England Peptide (NEP) has expanded its Massachusetts facility with a large scale production suite in a bid to meet demand for custom peptide and antibody services.

"We are seeing steadily increasing demand from customers for expertise in scaling up production quantities to hundreds of grams . . . this expansion gives us the capability to continue to meet this growing market need," NEP science and new technology senior vice president Sam Massoni said.

The 1,000 sq. ft. facility also reflected the company's planned entry into the worldwide market for clinical and commercial-grade peptides.

http://www.outsourcing-pharma.com/news/ng.asp?n=81934&m=2OSPD14&c=ixbkxdppfqdyheh

Testimonials

"Over the past 8 years we have used NEP for synthesis of many hundreds of peptides. The quality of NEP’s product is consistently very high. The company is deeply knowledgeable in all aspects of peptide synthesis, highly collaborative, and keenly interested in meeting the changing needs of their customers with respect to scale and formatting for delivery of peptides. One example is their flash-purified product which meets the need for initial draft-level evaluation without breaking the bank. Our experience with NEP’s antibody production capabilities has also been very good..."
Steven Carr, PhD - Director of Proteomics, Broad Institute